Kowa Pharmaceuticals America, Inc announced on Monday that the FDA in the United States approved their new drug, Cambia, for migraine.
Cambia is a combination drug. First, it’s a diclofenac based non-steroidal anti-inflammatory drug (NSAID). There are many many brands in this category, including Cataflam, Arthrotec, Zolterol, and Diclon. This type of NSAID is often [...]
{ 0 comments }


